Congresswoman Maloney Prevented from Testifying on EC for Rape Survivors
Congresswoman Carolyn Maloney (D-NY) was prevented from testifying on Thursday about the need to include information on emergency contraception in the Department of Justice's (DOJ) guidelines for the treatment of sexual assault victims before an advisory committee working to strengthen the federal Violence Against Women Act. Rep. Maloney was told that if she did not leave, security would escort her out, according to her office. A spokesman for DOJ told Newsday that Maloney was asked to leave because she had not registered to speak in time. “Today’s unfortunate incident raises questions about the basic willingness of the Justice Department to hear public comment on its decisions regarding women’s health,” Maloney said in a statement released by her office on Thursday.
The Justice Department's guidelines, published for the first time last September, currently do not mention offering EC to rape victims - an omission that has spurred criticism from many women’s, civil liberties, and health groups across the country. Last month, 97 US lawmakers, led by Maloney, sent a letter to Diane Stuart, Director of DOJ’s Office on Violence Against Women, in which they "strongly urged" the revision of its new guidelines for the treatment of sexual assault survivors to include information about emergency contraception (EC). Maloney said, "It is clear that the administration's ideological opposition to choice now even extends to rape victims. Women who are sexually violated at the very least deserve the right to prevent unwanted pregnancies."
EC is exceedingly safe and effective if taken within 5 days but it is most effective (95 percent) if taken within 24 hours after any unprotected sexual intercourse, when a condom breaks, or after a sexual assault. EC has the potential to cut in half the 3 million unintended pregnancies in the United States each year and prevent as many as 800,000 abortions a year. In some states, such as New York, hospitals are bound by law to offer emergency contraception to rape victims.
10/12/2015 Report Finds Texas' HB2 Increases Abortion Wait Times - A new report released by the University of Texas at Austin, Texas Policy Evaluation Project found patients seeking abortions in Texas have experienced an increase in wait times since the passage of HB2, the 2013 Texas omnibus anti-abortion bill that attempts to cut off abortion access by requiring abortion providers in the state to fulfill medically unnecessary ambulatory surgical center requirements and secure hospital admitting privileges.
More than half of 42 clinics providing abortion in Texas have been forced to shut their doors since HB2 passed two years ago, leading Texas women to wait up to 20 days for a first consult at one of the surviving 18 reproductive health clinics operating in the state, the second most populous in the nation. . . .
10/9/2015 Federal Judge Orders Anti-Abortion Group to Cede Footage to NAF - On Tuesday, a federal judge ruled that anti-abortion group Center for Medical Progress (CMP) and its leader David Daleidan must turn over all previously unreleased "sting" videos and outtakes of National Abortion Federation (NAF) meetings the group obtained surreptitiously as part of a smear campaign against the abortion provider.
U.S. . . .
10/9/2015 Women Scientists Receive Less Funding Than Their Male Peers, Study Finds - According to a new study published by the Journal of the American Medical Association, male scientists receive twice as much financial support to kickstart their careers in science and medicine as their female counterparts, an early career inequity that could limit professional opportunities for women scientists throughout their working lives.
Conducted by Health Resources in Action (HRiA), analysts studied 219 biomedical researchers who had applied for early-career grant funding at 55 New England hospitals, universities and research facilities between 2012 and 2014. . . .